CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug mavacamten shows promise in shrinking thickened heart muscle
Disease control OngoingThis study looks at whether the drug mavacamten can improve heart structure in 63 adults with a condition that makes the heart muscle too thick and blocks blood flow. Participants take the medication and have MRI scans to measure changes in heart size and thickness over 48 weeks.…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
Heart procedure may beat drugs for deadly rhythm disorder
Disease control OngoingThis study compares two treatments for a dangerous heart rhythm called ventricular tachycardia (VT) in people with structural heart disease. One treatment is a procedure called catheter ablation, which destroys the tiny area of heart tissue causing the problem. The other is stand…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC